The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of variables that may impact the use of Oncotype DX testing.
Stephen Szabo
Employment or Leadership Position - Georgia Cancer Specialist
Consultant or Advisory Role - Amgen
James W. Gilmore
No relevant relationships to disclose
Sally Haislip
No relevant relationships to disclose
Robert Hassell
Employment or Leadership Position - Cardinal Health
Joseph Cooper
Employment or Leadership Position - Cardinal Health Specialty Solutions
Steve Richardson
Employment or Leadership Position - Genomic Health
Meghan Fitzgerald
Employment or Leadership Position - Cardinal Health
Stock Ownership - Cardinal Health
Bruce A. Feinberg
Employment or Leadership Position - Cardinal Health
Stock Ownership - Cardinal Health